1. Stem Cell/Wnt NF-κB Metabolic Enzyme/Protease Immunology/Inflammation
  2. Wnt Reactive Oxygen Species (ROS) Endogenous Metabolite
  3. Methyl vanillate

Methyl vanillate  (Synonyms: バニリン酸メチル; 4-ヒドロキシ-3-メトキシ安息香酸メチル)

製品番号: HY-75342 純度: 99.88%
COA 取扱説明書 Technical Support

Methyl vanillate, one of the ingredients in Oryza sativa Linn., is a Wnt/β-catenin pathway activator. A benzoate ester that is the methyl ester of vanillic acid. It has a role as an antioxidant and a plant metabolite.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Methyl vanillate

Methyl vanillate 構造式

CAS 番号 : 3943-74-6

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 33 在庫あり
Solution
10 mM * 1 mL in DMSO USD 33 在庫あり
Solid
500 mg $30 在庫あり
1 g $40 在庫あり
5 g $60 在庫あり
10 g $75 在庫あり
25 g $110 在庫あり
50 g $140 在庫あり
100 g $185 在庫あり
> 100 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 2 publication(s) in Google Scholar

Other Forms of Methyl vanillate:

Top Publications Citing Use of Products

Wnt アイソフォーム固有の製品をすべて表示:

Endogenous Metabolite アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

Methyl vanillate, one of the ingredients in Oryza sativa Linn., is a Wnt/β-catenin pathway activator[1]. A benzoate ester that is the methyl ester of vanillic acid. It has a role as an antioxidant and a plant metabolite.

IC50 & Target

Human Endogenous Metabolite

 

Cellular Effect
Cell Line Type Value Description References
A549 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human A549 cells after 24 hrs by MTT assay
Anticancer activity against human A549 cells after 24 hrs by MTT assay
[PMID: 20466556]
A549 IC50
>100 3
Compound: 1bMe
Anticancer activity against human A549 cells after 24 hrs by MTT assay
Anticancer activity against human A549 cells after 24 hrs by MTT assay
[PMID: 20466556]
A549 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human A549 cells after 24 hrs by MTT assay
Anticancer activity against human A549 cells after 24 hrs by MTT assay
[PMID: 20466556]
B16-F10 IC50
> 100 3
Compound: 1bMe
Anticancer activity against mouse B16F10 cells after 24 hrs by MTT assay
Anticancer activity against mouse B16F10 cells after 24 hrs by MTT assay
[PMID: 20466556]
B16-F10 IC50
>100 3
Compound: 1bMe
Anticancer activity against mouse B16F10 cells after 24 hrs by MTT assay
Anticancer activity against mouse B16F10 cells after 24 hrs by MTT assay
[PMID: 20466556]
B16-F10 IC50
> 100 3
Compound: 1bMe
Anticancer activity against mouse B16F10 cells after 24 hrs by MTT assay
Anticancer activity against mouse B16F10 cells after 24 hrs by MTT assay
[PMID: 20466556]
Hs 683 IC50
>100 3
Compound: 1bMe
Anticancer activity against human Hs683 cells after 24 hrs by MTT assay
Anticancer activity against human Hs683 cells after 24 hrs by MTT assay
[PMID: 20466556]
Hs 683 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human Hs683 cells after 24 hrs by MTT assay
Anticancer activity against human Hs683 cells after 24 hrs by MTT assay
[PMID: 20466556]
LoVo IC50
83 3
Compound: 1bMe
Anticancer activity against human LoVo cells after 24 hrs by MTT assay
Anticancer activity against human LoVo cells after 24 hrs by MTT assay
[PMID: 20466556]
Hs 683 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human Hs683 cells after 24 hrs by MTT assay
Anticancer activity against human Hs683 cells after 24 hrs by MTT assay
[PMID: 20466556]
LoVo IC50
83 3
Compound: 1bMe
Anticancer activity against human LoVo cells after 24 hrs by MTT assay
Anticancer activity against human LoVo cells after 24 hrs by MTT assay
[PMID: 20466556]
LoVo IC50
83 3
Compound: 1bMe
Anticancer activity against human LoVo cells after 24 hrs by MTT assay
Anticancer activity against human LoVo cells after 24 hrs by MTT assay
[PMID: 20466556]
MCF7 IC50
>100 3
Compound: 1bMe
Anticancer activity against human MCF7 cells after 24 hrs by MTT assay
Anticancer activity against human MCF7 cells after 24 hrs by MTT assay
[PMID: 20466556]
MCF7 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human MCF7 cells after 24 hrs by MTT assay
Anticancer activity against human MCF7 cells after 24 hrs by MTT assay
[PMID: 20466556]
MCF7 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human MCF7 cells after 24 hrs by MTT assay
Anticancer activity against human MCF7 cells after 24 hrs by MTT assay
[PMID: 20466556]
OE33 IC50
>100 3
Compound: 1bMe
Anticancer activity against human OE33 cells after 24 hrs by MTT assay
Anticancer activity against human OE33 cells after 24 hrs by MTT assay
[PMID: 20466556]
OE33 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human OE33 cells after 24 hrs by MTT assay
Anticancer activity against human OE33 cells after 24 hrs by MTT assay
[PMID: 20466556]
PC-3 IC50
>100 3
Compound: 1bMe
Anticancer activity against human PC3 cells after 24 hrs by MTT assay
Anticancer activity against human PC3 cells after 24 hrs by MTT assay
[PMID: 20466556]
PC-3 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human PC3 cells after 24 hrs by MTT assay
Anticancer activity against human PC3 cells after 24 hrs by MTT assay
[PMID: 20466556]
OE33 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human OE33 cells after 24 hrs by MTT assay
Anticancer activity against human OE33 cells after 24 hrs by MTT assay
[PMID: 20466556]
PC-3 IC50
> 100 3
Compound: 1bMe
Anticancer activity against human PC3 cells after 24 hrs by MTT assay
Anticancer activity against human PC3 cells after 24 hrs by MTT assay
[PMID: 20466556]
RBL-2H3 IC50
640 3
Compound: 1
Anti-allergic activity in RBL2H3 cells assessed as inhibition of anti-DNP-IgE-induced degranulation incubated for 20 mins followed by DNP-labeled human serum albumin addition measured after 1 hr by beta-hexosaminidase release assay
Anti-allergic activity in RBL2H3 cells assessed as inhibition of anti-DNP-IgE-induced degranulation incubated for 20 mins followed by DNP-labeled human serum albumin addition measured after 1 hr by beta-hexosaminidase release assay
[PMID: 27324979]
RBL-2H3 IC50
640 3
Compound: 1
Anti-allergic activity in RBL2H3 cells assessed as inhibition of anti-DNP-IgE-induced degranulation incubated for 20 mins followed by DNP-labeled human serum albumin addition measured after 1 hr by beta-hexosaminidase release assay
Anti-allergic activity in RBL2H3 cells assessed as inhibition of anti-DNP-IgE-induced degranulation incubated for 20 mins followed by DNP-labeled human serum albumin addition measured after 1 hr by beta-hexosaminidase release assay
[PMID: 27324979]
RBL-2H3 IC50
640 3
Compound: 1
Anti-allergic activity in RBL2H3 cells assessed as inhibition of anti-DNP-IgE-induced degranulation incubated for 20 mins followed by DNP-labeled human serum albumin addition measured after 1 hr by beta-hexosaminidase release assay
Anti-allergic activity in RBL2H3 cells assessed as inhibition of anti-DNP-IgE-induced degranulation incubated for 20 mins followed by DNP-labeled human serum albumin addition measured after 1 hr by beta-hexosaminidase release assay
[PMID: 27324979]
T98G IC50
>100 3
Compound: 1bMe
Anticancer activity against human T98G cells after 24 hrs by MTT assay
Anticancer activity against human T98G cells after 24 hrs by MTT assay
[PMID: 20466556]
T98G IC50
> 100 3
Compound: 1bMe
Anticancer activity against human T98G cells after 24 hrs by MTT assay
Anticancer activity against human T98G cells after 24 hrs by MTT assay
[PMID: 20466556]
T98G IC50
> 100 3
Compound: 1bMe
Anticancer activity against human T98G cells after 24 hrs by MTT assay
Anticancer activity against human T98G cells after 24 hrs by MTT assay
[PMID: 20466556]
U-373MG ATCC IC50
>100 3
Compound: 1bMe
Anticancer activity against human U373 cells after 24 hrs by MTT assay
Anticancer activity against human U373 cells after 24 hrs by MTT assay
[PMID: 20466556]
U-373MG ATCC IC50
> 100 3
Compound: 1bMe
Anticancer activity against human U373 cells after 24 hrs by MTT assay
Anticancer activity against human U373 cells after 24 hrs by MTT assay
[PMID: 20466556]
U-373MG ATCC IC50
> 100 3
Compound: 1bMe
Anticancer activity against human U373 cells after 24 hrs by MTT assay
Anticancer activity against human U373 cells after 24 hrs by MTT assay
[PMID: 20466556]
体外実験

Methyl vanillate (0-100 μM) increases the expression and nuclear translocation of β-catenin in calvarial osteoblasts. Methyl vanillate dose-dependently elevates ALP activity in calvarial osteoblasts[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

182.17

分子式

C9H10O4

CAS 番号
Appearance

Solid

Color

Off-white to light brown

SMILES

O=C(OC)C(C=C1)=CC(OC)=C1O

Structure Classification
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

4°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

溶剤 & 溶解度
体外: 

DMSO : ≥ 100 mg/mL (548.94 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H2O : 1.67 mg/mL (9.17 mM; Need ultrasonic)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 5.4894 mL 27.4469 mL 54.8938 mL
5 mM 1.0979 mL 5.4894 mL 10.9788 mL
10 mM 0.5489 mL 2.7447 mL 5.4894 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始)

C1

×
体積 (開始)

V1

=
濃度 (終了)

C2

×
体積 (終了)

V2

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (13.72 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (13.72 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  PBS

    Solubility: 2 mg/mL (10.98 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション

純度: 99.88%

参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
H2O / DMSO 1 mM 5.4894 mL 27.4469 mL 54.8938 mL 137.2345 mL
5 mM 1.0979 mL 5.4894 mL 10.9788 mL 27.4469 mL
DMSO 10 mM 0.5489 mL 2.7447 mL 5.4894 mL 13.7234 mL
15 mM 0.3660 mL 1.8298 mL 3.6596 mL 9.1490 mL
20 mM 0.2745 mL 1.3723 mL 2.7447 mL 6.8617 mL
25 mM 0.2196 mL 1.0979 mL 2.1958 mL 5.4894 mL
30 mM 0.1830 mL 0.9149 mL 1.8298 mL 4.5745 mL
40 mM 0.1372 mL 0.6862 mL 1.3723 mL 3.4309 mL
50 mM 0.1098 mL 0.5489 mL 1.0979 mL 2.7447 mL
60 mM 0.0915 mL 0.4574 mL 0.9149 mL 2.2872 mL
80 mM 0.0686 mL 0.3431 mL 0.6862 mL 1.7154 mL
100 mM 0.0549 mL 0.2745 mL 0.5489 mL 1.3723 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
Methyl vanillate
製品番号:
HY-75342
数量:
MCE 日本正規代理店: